J&J’s consumer health unit Kenvue aims to raise $3.5 billion or more in the initial public offering, sources told The Wall Street Journal.
More Stories
Curve Finance considers dropping TUSD from crvUSD backing amid SEC charges
Curve Finance is considering dropping TUSD from crvUSD backing amid SEC charges. The SEC alleges TUSD was mostly backed by...
Worldcoin soars as World ID expands to three more countries
Worldcoin price rose 23% to hit $2.14 and outperform all top 100 coins by market cap by 24-hour gains. The...
Investor Paul Viera doubles his San Antonio Spurs stake in a steep discount deal
The deal for a piece of the Spurs comes as NBA valuations rise on the back of an 11-year, $76...
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the...
The Curious Inability To Spend Money On Yourself
Recently, I hit a major milestone in my journey to overcome what I like to call “frugality disease.” I spent...
SEC charges Merrill Lynch, Harvest Volatility Management for ignoring client investment limits
They will pay a combined $9.3 million after the Securities and Exchange Commission charged them for exceeding clients' investment limits...